Search Results For :: non-destructive testing
-
European Food Safety Testing Market By Contaminant (Pathogen, GMO, Toxin, Pesticide), Technology (Traditional & Rapid), Food Type (Meat & Poultry Product, Dairy Product, Fruit & Vegetable, Processed Food) & Country - Trends & Forecast To 2018
Increasing outbreak of foodborne illnesses and poisoning risks in Europe has resulted European Food Safety Authority (EFSA) to impose strict food safety regulations. The food safety regulations specify maximum permitted level of any contaminant in food. EFSA has also specified that all the food manufacturers are responsible for safety of food. So, food safety testing has to be implemented during all the stage of food production to ensure absence of contaminations and prevent any potential health risks upon consumption of contaminated food. The regulatory bodies in Europe have been implementing Hazard Analysis Critical Control Point (HACCP) systems to ensure food safety. Implementation of these food safety regulations has been driving the food safety testing market. Globalization of food supply and demand of the consumer for food safety and information has further helped the market to grow.
- Published: July 2013
- Price: $ 4950
- TOC Available:
-
Asia-Pacific Seed Treatment Market By Type (Chemical & Non-Chemical), By Application (Fungicide, Insecticide, Bio-Control And Others) And By Crop (Cereals, Oilseeds And Others): Trends, Forecasts And Technical Insights Up To 2018
The seed treatment market consists of crop protection chemicals or agrochemicals, specifically for seeds, and genetically modified (GM) crop-seeds. Crop protection chemicals are the most dominating segment of this market in terms of market share as well as product innovations. Seed treatment market is further classified as insecticides (chemical), fungicides (chemical), bio-control seed treatments, and other seed treatment chemicals.
- Published: April 2013
- Price: $ 4950
- TOC Available:
-
North America Seed Treatment Market by Type (chemical & non-chemical), by Application (fungicide, insecticide, bio-control and others) and by Crop (cereals, oilseeds and others): Trends, Forecasts and Technical Insights up to 2018
The seed treatment market consists of crop protection chemicals or agrochemicals, specifically for seeds, and genetically modified (GM) crop-seeds. Crop protection chemicals are the most dominating segment of this market in terms of market share as well as product innovations. Seed treatment market is further classified as insecticides (chemical), fungicides (chemical), bio-control seed treatments, and other seed treatment chemicals.
- Published: April 2013
- Price: $ 4950
- TOC Available:
-
Minimally Invasive and Non Invasive Product and Service Market (2009 - 2014)
This report will analyze the market potential for minimally invasive/non-invasive surgery. The target segment (end-users) of the minimal invasive/non-invasive surgery products are mainly hospital surgical departments, outpatient surgery centers, group medical practices, individual surgeons, and medical schools. The number of outpatient centers is set to rise, as a low cost alternative for hospitals.
- Published: July 2009
- Price: $ 4950
- TOC Available:
-
Medical Membranes Market by Material (PSU, PES, PVDF, PTFE, PP, PAN, PA, Modified Acrylics), Process Technology (Ultrafiltration, Microfiltration, Nanofiltration), Application (Pharmaceutical Filtration, Hemodialysis, IV Fusion & Sterile Filtration, Membrane Oxygenator), and Region - Global Forecast to 2030
The medical membranes market is expected to grow from USD 4.31 billion in 2025 to USD 6.66 billion by 2030, at a compound annual growth rate (CAGR) of 9.1% during the forecast period. The Key Players Asahi Kasei Corporation (Japan), Mann+Hummel (Germany), Sartorius AG (Germany), Merck KGaA (Germany), Solventum (US), Cytiva (US), W. L. Gore & Associates, Inc. (US), Kovalus Separation Solutions (US), and Cobetter (China).
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Biochips Market by Products & Services (Instruments, Software), Type (DNA Chips, Protein Chips, Lab-on-a-Chip), Application (High-throughput Screening, IVD, POC), Fabrication Technology (Microarrays, Microfluidics), & Region - Global Forecast to 2030
The global biochips market, valued at US$12,907.5 million in 2024, stood at US$14,011.6 million in 2025 and is projected to advance at a resilient CAGR of 8.8% from 2024 to 2030, culminating in a forecasted valuation of US$21,356.4 million by the end of the period.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Life Science Instrumentation Market by Technology (Spectroscopy, Chromatography, Immunoassay, NGS, PCR, Microscopy), Application (Diagnostic, Clinical), End User (Pharma, Agriculture & Food Industry, Hospital, Diagnostic Lab) - Global Forecasts to 2031
The global Life Science Instrumentation market, valued at US$59.9 billion in 2024, stood at US$63.4 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2024 to 2030, culminating in a forecasted valuation of US$92.5 billion by the end of the period. The main drivers of the life science instrumentation market include increasing demand for advanced analytical technologies in drug discovery, genomics, and proteomics research, along with rising investments in pharmaceutical and biotechnology R&D.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Preimplantation Genetic Testing Market by Product & Service (Reagents, Consumables, Instruments, Software), Technology (NGS, PCR, SNP, CGH), Procedure (Screening, Diagnosis), Application (Aneuploidy, HLA Typing), Type of cycle - Global Forecast to 2030
The global preimplantation genetic testing market, valued at US$636.4 million in 2024, stood at US$690.2 million in 2025 and is projected to advance at a resilient CAGR of 10.5% from 2024 to 2030, culminating in a forecasted valuation of US$1,135.0 million by the end of the period.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Biosimilars Market by Drug Class (mAbs (Adalimumab, Infliximab, Rituximab, Trastuzumab), GCSF, Insulin, Anticoagulant, rhGH, Teriparatide, GLP-1), Indication (Oncology, Autoimmune, Diabetes, Obesity), Competitive Landscape, Region - Global Forecast to 2035
The global biosimilars market, valued at US$32.75 billion in 2024, stood at US$35.04 billion in 2025 and is projected to advance at a resilient CAGR of 7.5% from 2025 to 2035, culminating in a forecasted valuation of US$72.29 billion by the end of the period. This growth is driven by several key factors, including a rising number of regulatory approvals and product launches, the patent expiries of major biologics, and the increasing prevalence of chronic diseases that require effective and affordable treatment options.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Biomarkers Market by Offering (Consumables, Software, Services), Type (Safety, Efficacy), Research Area (Genomics, Proteomics), Technology (PCR, MS), Disease (Cancer, Infectious, Neurological), Application (Diagnostic, Research) - Global Forecast to 2030
The global biomarkers market, valued at US$58.07 billion in 2024, stood at US$62.39 billion in 2025 and is projected to advance at a resilient CAGR of 10.8% from 2025 to 2030, culminating in a forecasted valuation of US$104.15 billion by the end of the period. This growth is supported by the growing use of biomarkers in drug development and the increasing role of companion diagnostics in advancing precision medicine.
- Published: May 2025
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 63
